In Treatment of Ifosfamide-induced hemorrhagic cystitis Ifosfamide-induced hemorrhagic cystitis is an inflammatory condition due to the use of a medicine called Ifosfamide that causes bleeding in the bladder. Uromitexan Infusion helps to suppress the body’s immune system, thereby reducing the progression of the disease. It reduces the inflammation of the damaged area, prevents further damage, and stabilises your condition
It is not known whether it is safe to consume alcohol with Uromitexan Infusion. Please consult your doctor.
Uromitexan Infusion is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Uromitexan Infusion is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Uromitexan Infusion may cause side effects which could affect your ability to drive. As patients undergoing treatment with Uromitexan Infusion may experience undesirable effects such as lightheadedness, lethargy, dizziness, and blurred vision which could affect the ability to drive.
Uromitexan Infusion should be used with caution in patients with kidney disease. Dose adjustment of Uromitexan Infusion may be needed. Please consult your doctor.
Uromitexan Infusion should be used with caution in patients with liver disease. Dose adjustment of Uromitexan Infusion may be needed. Please consult your doctor.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Zydus Cadila || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Zydus Cadila || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Dr Reddy's Laboratories Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Neon Laboratories Ltd || ₹14.5/tablet (25% cheaper)